Biotech Restructuring: Pharma Giant Cuts Jobs Amidst Shifting Priorities

Biotech Bloodbath: A major pharmaceutical company slashes 400 jobs in a restructuring shakeup! Facing rising costs and expiring patents, the company is pivoting to high-growth areas like cancer and rare disease treatments, sparking industry-wide concerns about innovation and the future of drug development. Will this gamble pay off, or will the loss of experienced researchers stall crucial progress?The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.